A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) Administered to Patients With Familial Chylomicronemia Syndrome (FCS)

NCT04568434 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Chylomicronemia Syndrome

Interventions

DRUG: Olezarsen
DRUG: Placebo

Sponsor

Ionis Pharmaceuticals, Inc.